Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
SYDNEY—Insignia Financial on Monday said Bain Capital has matched a US$1.8 billion takeover offer by CC Capital Partners, intensifying a tussle for control of the Australian wealth manager.
TOKYO -- U.S. investment fund Bain Capital will acquire Japanese aircraft interior maker Jamco for a total of around 100 billion yen ($634 million), including its debt, in another move by the ...